by Vandana Singh | Jan 12, 2026 | General
On Saturday, Johnson & Johnson (NYSE:JNJ) shared new longer follow-up results from the Phase 1b/2 OrigAMI-1 study. The trial is evaluating Rybrevant (amivantamab-vmjw) in combination with FOLFOX or FOLFIRI chemotherapy for RAS/BRAF wild-type metastatic colorectal...
by Piero Cingari | Jan 12, 2026 | General
Gold and silver surged to fresh record highs Monday as investors reassessed the Federal Reserve’s independence fears amid a new political escalation. • MACOM Technology stok is approaching key resistance levels. What’s behind MTSI new highs? Gold prices — as...
by Avi Kapoor | Jan 12, 2026 | General
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 50 points on Monday. The Dow traded down 0.19% to 49,411.94 while the NASDAQ gained 0.29% to 23,740.51. The S&P 500 also rose, gaining, 0.04% to 6,969.38. Check This Out:...
by Vandana Singh | Jan 12, 2026 | General
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Royalty Pharma plc (NASDAQ:RPRX) announced on Sunday a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-‘408. IL-15 is a key cytokine involved in...
by Anusuya Lahiri | Jan 12, 2026 | General
Critical Metals Corp. (NASDAQ:CRML) announced on Monday that it has ordered a fully turnkey Integrated Mobile Geochemical Analysis Centre from Bromet, investing approximately $1 million to accelerate assay turnaround times at its Tanbreez rare earth elements project...
Recent Comments